In breast cancer, the expression of LDHB is lower in malignant tumors than the benign tumors and is preferential in cancer-associated adipocytes [59], implying the tissue specificity of LDHB expression in the tumor cells and stromal cells of TME. The gene discussed is LDHB; the disease is benign neoplasm.